title: Fenofibrate-induced liver injury.
authors.forename: Kazufumi
authors.initials: K
authors.lastname: Dohmen
authors.forename: Chun Yang
authors.initials: CY
authors.lastname: Wen
authors.forename: Shinya
authors.initials: S
authors.lastname: Nagaoka
authors.forename: Koji
authors.initials: K
authors.lastname: Yano
authors.forename: Seigo
authors.initials: S
authors.lastname: Abiru
authors.forename: Toshihito
authors.initials: T
authors.lastname: Ueki
authors.forename: Atsumasa
authors.initials: A
authors.lastname: Komori
authors.forename: Manabu
authors.initials: M
authors.lastname: Daikoku
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yatsuhashi
authors.forename: Hiromi
authors.initials: H
authors.lastname: Ishibashi
mesh_terms: D000368:Aged; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects*; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy; D047493:PPAR alpha / Q000502:physiology; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
chemical_list: D047493:PPAR alpha; D014580:Ursodeoxycholic Acid; D011345:Fenofibrate